Skip to main content
OpenTrials

Clinical trial condition

Eczema

Explore clinical trials studying Eczema. Study availability and eligibility vary by location and protocol.

352 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Eczema trial results

Completed

A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

NCT03443024

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Clear Dermatology & Aesthetics Center Scottsdale, Arizona, United States
  • Dermatology Trial Associates Bryant, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
View all 58 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

NCT03011892

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • UAB DERMATOLOGY, 2000 6th Avenue South Birmingham, Alabama, United States
  • BURKE PHARMACEUTICAL RESEARCH, 601 W. Commerce Bryant, Arkansas, United States
  • ENCINO RESEARCH CENTER, 16133 Ventura Blvd Encino, California, United States
  • DERMATOLOGY RESEARCH ASSOCIATES,8930 South Sepulveda Blvd Los Angeles, California, United States
View all 52 locations
View Trial Details
Completed

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

NCT01756898

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Rogers, Arkansas, United States
  • Encino, California, United States
View all 40 locations
View Trial Details
Completed

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03720470

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • The University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Marvel Research, LLC Huntington Beach, California, United States
  • Alliance Research Centers Laguna Hills, California, United States
View all 216 locations
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

NCT01428297

Conditions
Abnormalities, Multiple, Atopic Dermatitis, Congenital Abnormalities, +19 more
Locations
  • Novartis Investigative Site New Haven, Connecticut, United States
  • Novartis Investigative Site St Louis, Missouri, United States
  • Novartis Investigative Site Fargo, North Dakota, United States
  • Novartis Investigative Site Utrecht, The Netherlands, Netherlands
View Trial Details
Completed

A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)

NCT02407756

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Markham, Ontario, Canada
  • Peterborough, Ontario, Canada
  • Waterloo, Ontario, Canada
  • Windsor, Ontario, Canada
View all 26 locations
View Trial Details

Related conditions